Notice
Products
Resources
Log inSign up
  • Trading
  • Monitoring
  • Research
  • Notice Pro
  • Screener
  • Notice 50
  • nav.rankings
  • nav.ipoCalendar
  • Trends
  • About
  • Help center
Viome Stock

Viome Stock

Last updated on June 19, 2025
1.88
-0.004
(-0.23%)
Past consensus
3.01Retail max
OverviewMarketValuationRevenueFundingInvestors

Viome Stock Price Chart

Viome stock price is built algorithmically using secondary market and reference data. Learn more Disclosures

How to buy Viome

The world's most experienced Viome brokers are here to advise you on buying and selling opportunities.

About Viome, Inc.

Viome offers a direct-to-consumer healthcare test that analyzes microbial and human gene expressions (mRNA). This groundbreaking technology, exclusively licensed from Los Alamos National Lab, provides individuals with health insights and personalized nutritional recommendations. By joining Viome, individuals become part of a revolutionary movement that empowers them to take control of their well-being. With over a decade of scientific research, Viome's technology offers unprecedented visibility into the body, creating a unique profile of one's biochemistry and ecosystem. The at-home tests serve as true health companions, enabling individuals to monitor their health over time and receive adaptive recommendations for optimizing vitality and lifespan.

Founded
2016
Employees
92
Website
viome.com
Last round
-
Market Cap
$339.00 M1
Premium
-
Total Funding
-
Days Since Funding
2812
Coverage Ratio
-
Health & Wellness
Oncology
Biotech
1
Last round valuation used because market cap cannot be calculated

Viome Market

Transferability unknown
We do not know if Viome allows direct stock transfers. if you know the current transfer rules for Viome.
Viome has low market activity. There are no buyers or sellers of Viome at this time. It can take time for markets to develop around private companies. Buyer demand typically drives markets in private companies. Here are the major factors:
  • News: Positive company developments that garner extensive news coverage including large funding rounds or product launches can generate investor demand.
  • Size: Investor demand also tends to be correlated with company valuation where the larger companies attract more secondary market investor attention.
  • Sector: Hot sectors like AI can create halo effects that drive investor demand more broadly into the sector as a whole.
  • Age: Finally, older companies typically have more sellers as employees have vested and investors are pushed to liquidate positions to generate returns.
So, older large companies with continuous positive news cycles in hot sectors tend to be the most liquid. SpaceX is a good example of a highly liquid name.
or sign up and post an indication of interest to explore opportunities to transact Viome.

Viome Stock Price

Quarterly performance

Viome stock is not currently traded in the private markets. We do not have enough data to print a price history for Viome right now. If you can share any Viome stock trade data or funding round price per share, then we can start pricing coverage for Viome.

Viome Valuation

We are missing all Viome funding round valuations. Sometimes these details are not shared in funding announcements or corporate filings. If you can share valuations for any funding rounds that Viome has done, then we can start valuation coverage for Viome.

Frequently Asked Questions

Does Viome have stock?

Yes. Viome is a private venture-backed company. Investors usually purchase preferred stock and employees typically receive common stock options or restricted stock units (RSUs) as part of their compensation.

What is Viome's stock symbol?

Since it is not publicly listed, there is no Viome stock symbol or Viome ticker symbol assigned for Viome.

Private companies typically reserve a stock symbol up to two years prior to an IPO, and disclose this when they file a Form S-1 with the Securities and Exchange Commission when they start the IPO process.

How can I sell Viome stock?

If you own shares of a private company, it may be possible to find liquidity for your holdings before the company goes public. Finding the right private market broker can make all the difference as the best brokers can leverage deep industry relationships and negotiate on your behalf.

If you are interested in selling private stock you can reach out to Premier brokers for more information.

How do Viome pre-IPO trades work?

Private market transactions can be complex and may involve company approvals, legal purchase agreements and wires to third parties. Trades can take 30 - 60 days to complete which is why many investors work with experienced private market brokers to help guide the process.

Direct share transfers typically require issuer approvals. Issuers may exercise the right of first refusal (ROFR) in order to direct the seller to a buyer of their choosing.

Some issuers do not allow transactions. In these cases, buyers will need to purchase indirect interests in the business via special purpose vehicles (SPVs) or forward purchase contracts (forwards).

Is Viome publicly traded?

Viome stock does not trade publicly on Nasdaq or NYSE because it is still a private company. Viome stock might be available for purchase in the secondary markets, but Viome stock is not available for purchase by the general public, and can not be purchased through traditional brokerage accounts.

How can I buy Viome stock?

Only accredited investors and qualified purchasers can buy private stock. These investors buy pre-IPO stock in the secondary market from existing employees and investors.

To learn more about the market for Viome stock, talk to the best brokers on the planet.

How to invest in Viome?

Accredited investors can purchase shares in private companies like Viome. Investors can rely on Notice Premier Brokers to find supply and guide them through the trading process.

Because Viome is privately held, its stock is not available for purchase through public stock exchanges like the NYSE or Nasdaq. Retail investors can not access this stock via traditional brokerage accounts, and are not allowed to invest directly in Viome pre-IPO.

How is Notice pricing Viome?

Notice Price is algorithmically generated based on a number of inputs like private market activity, official company filings, internal marks, and comparables.

Developing accurate pricing for the private market, and making that pricing available to everyone has always been our mission.

  1. Notice
  2. /
  3. Companies
  4. /
  5. Health & Wellness
  6. /
  7. Oncology

Popular companies

©2025 Notice, Inc.TermsPrivacyDisclaimersLearn
LinkedInTwitterFacebookMedium
IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON NOTICE.CO ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT. NOTICE, INC., TOGETHER WITH ITS AFFILIATES ("NOTICE") IS NOT A BROKER-DEALER, INVESTMENT ADVISER OR ANY OTHER TYPE OF FINANCIAL PROFESSIONAL. NO PLATFORM CONTENT SHOULD BE CONSIDERED AN OFFER, SOLICITATION OF AN OFFER, OR ADVICE TO BUY OR SELL SECURITIES OR ANY OTHER TYPE OF INVESTMENT OR FINANCIAL PRODUCT. BY USING THE PLATFORM YOU UNDERSTAND AND AGREE THAT NOTICE DOES NOT PROVIDE INVESTMENT ADVICE; RECOMMEND ANY SECURITY, TRANSACTION OR ORDER; FACILITATE BROKERAGE REFERRALS; OR PROVIDE ANY OTHER TYPE OF FINANCIAL PRODUCT OR SERVICE. YOU MAY NOT DIRECTLY PURCHASE SHARES OF PRIVATE COMPANIES ON THE PLATFORM. PRIVATE OFFERINGS AVAILABLE THROUGH THE PLATFORM INVOLVE THE OFFER AND SALE OF MEMBERSHIP INTERESTS IN LIMITED LIABILITY COMPANIES THAT MAY HOLD SHARES OF PRIVATE COMPANIES. ANY REFERENCES ON THE PLATFORM TO 'SHARES', 'PRICE PER SHARE', 'STOCK' OR OTHER SIMILAR TERMINOLOGY ARE FOR ADMINISTRATIVE CONVENIENCE ONLY. The content on the Notice website ("Platform") produced by Notice, in part, (the "Platform Content"), is based on aggregated data from the voluntary disclosure by certain of Notice's Users and/or publicly available information. Notice does not have an obligation to update Platform Content and none of the information provided by Notice constitutes investment, tax, or legal advice. All information provided by Notice is for informational purposes only. Platform Content is not an endorsement of and does not suggest any affiliation to any third parties related to the Platform Content. Notice makes no representations or warranties with respect to the Platform Content and will not be liable for Platform Content or any action (or inaction) taken in reliance on such Platform Content. Notice does not guarantee or makes any warranty of any kind, express or implied, regarding the timeliness, sequence, accuracy, or completeness of any Platform Content. All pricing information provided on the Platform is based on a number of factors, may not be accurate, and is not intended to reflect an active market, or the ability for any individual to transact at such prices. Notice does not independently verify any pricing information and assumes no responsibility for its accuracy. Pricing information displayed does not represent a quote or any other offer to buy or sell at any given price or quantity.
Airtable Stock
Airtable
56.15
-0.12
Anduril Stock
Anduril
53.97
-0.35
Anthropic Stock
Anthropic
65.88
-0.14
Apptronik Stock
Apptronik
17.05
-0.01
Canva Stock
Canva
1,125.67
-2.38
Cerebras Stock
Cerebras
33.43
+1.56
Cohere Stock
Cohere
163.47
-0.35
Cohesity Stock
Cohesity
16.81
-0.04
Cursor (Anysphere) Stock
Cursor (Anysphere)
228.31
-0.48
Databricks Stock
Databricks
108.02
-0.23
Discord Stock
Discord
241.35
-0.51
Epic Games Stock
Epic Games
451.15
-0.99
EquipmentShare Stock
EquipmentShare
10.69
+0.06
Figma Stock
Figma
34.10
-0.07
Figure AI Stock
Figure AI
194.09
+0.93
Firefly Aerospace Stock
Firefly Aerospace
5.93
-0.04
Flock Safety Stock
Flock Safety
16.13
+0.01
Gecko Robotics Stock
Gecko Robotics
48.33
+0.21
Glean Stock
Glean
50.06
-0.11
Groq Stock
Groq
25.21
+0.25